Publications

2026: Pregnane X receptor deletion induces a lean phenotype in chow-fed mice through a liver-ileum-muscle axis involving 6α-hydroxylated bile acids and Fgf15. Molecular Metabolism 

Transcriptomic profiling of co-cultured cancer-host cells identifies hypoxia as a driver of the skeletal muscle cell's anti-proliferative effect on cancer cells. Oncogenesis

2025: Therapeutic potential of FGF19 in combatting osteosarcopenia: effects on muscle strength and bone health in aged male mice. Journal of Bone and Mineral Research Plus

2024: Persistent organic pollutants disrupt the oxidant/antioxidant balance of INS-1E pancreatic β-cells causing their physiological dysfunctions. Environment International

2023: Mice lacking intestinal Nr1i2 have normal intestinal homeostasis under steady-state conditions and are not hypersensitive to inflammation under lipopolysaccharide treatment. FASEB Journal 

Treatment with fibroblast growth factor 19 increases skeletal muscle fiber size, ameliorates metabolic perturbations and hepatic inflammation in 5/6 nephrectomized mice. Science Reports 

2022: Associations between persistent organic pollutants and type 1 diabetes in youth. Environment International. 

2021: Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy. Journal of Cachexia, Sarcopenia and Muscle

2017: Fibroblast growth factor 19 regulates skeletal muscle mass and protects from muscle wasting. Nature Medicine